GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Merit Medical Systems Inc (NAS:MMSI) » Definitions » Altman Z-Score

Merit Medical Systems (Merit Medical Systems) Altman Z-Score : 4.13 (As of May. 04, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Merit Medical Systems Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 4.13 is strong.

Merit Medical Systems has a Altman Z-Score of 4.13, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Merit Medical Systems's Altman Z-Score or its related term are showing as below:

MMSI' s Altman Z-Score Range Over the Past 10 Years
Min: 2.35   Med: 3.81   Max: 6.62
Current: 4.13

During the past 13 years, Merit Medical Systems's highest Altman Z-Score was 6.62. The lowest was 2.35. And the median was 3.81.


Merit Medical Systems Altman Z-Score Historical Data

The historical data trend for Merit Medical Systems's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merit Medical Systems Altman Z-Score Chart

Merit Medical Systems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.35 3.67 4.77 6.17 3.88

Merit Medical Systems Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.53 6.07 5.72 3.88 4.02

Competitive Comparison of Merit Medical Systems's Altman Z-Score

For the Medical Instruments & Supplies subindustry, Merit Medical Systems's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merit Medical Systems's Altman Z-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Merit Medical Systems's Altman Z-Score falls into.



Merit Medical Systems Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Merit Medical Systems's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.3963+1.4*0.2594+3.3*0.0612+0.6*4.2246+1.0*0.5516
=4.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2024:
Total Assets was $2,326 Mil.
Total Current Assets was $1,105 Mil.
Total Current Liabilities was $183 Mil.
Retained Earnings was $603 Mil.
Pre-Tax Income was 34.348 + 31.467 + 30.222 + 24.9 = $121 Mil.
Interest Expense was -8.046 + -4.977 + -4.841 + -3.682 = $-22 Mil.
Revenue was 323.508 + 324.515 + 315.23 + 320.056 = $1,283 Mil.
Market Cap (Today) was $4,589 Mil.
Total Liabilities was $1,086 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(1105.275 - 183.344)/2326.352
=0.3963

X2=Retained Earnings/Total Assets
=603.424/2326.352
=0.2594

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(120.937 - -21.546)/2326.352
=0.0612

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=4588.603/1086.162
=4.2246

X5=Revenue/Total Assets
=1283.309/2326.352
=0.5516

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Merit Medical Systems has a Altman Z-Score of 4.13 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Merit Medical Systems  (NAS:MMSI) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Merit Medical Systems Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Merit Medical Systems's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Merit Medical Systems (Merit Medical Systems) Business Description

Traded in Other Exchanges
Address
1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. Majority of the revenue is earned from Cardiovascular segment. United States generates majority of the revenue.
Executives
F. Ann Millner director 4275 SPRING ROAD, OGDEN UT 84403
Neil Peterson officer: Chief Operating Officer 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
A Scott Anderson director ONE SOUTH MAIN, SUITE 1134, SALT LAKE CITY UT 84111
Michel James Voigt officer: Chief Human Resources Officer 1600 W MERIT PARKWAY, SOUTH JORDAN UT 84095
Fred P Lampropoulos director, officer: President & CEO
Lynne Ward director 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Raul Jr. Parra officer: Interim CFO 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Joseph Wright officer: President, International 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Brian G. Lloyd officer: Chief Legal Officer, Secretary 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Ronald Frost officer: Chief Operating Officer 1600 WEST MERIT PARKWAY, SOUTH JORDAN X1 84095
Robert Fredericks officer: Chief Strategy & Innovation O. 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Laura S. Kaiser director 10101 WOODFIELD LANE, ST. LOUIS MO 63132
Michael R Mcdonnell director C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
Jill Anderson director 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Stephen C. Evans director C/O ALARM.COM HOLDINGS, INC., 8281 GREENSBORO DRIVE, SUITE 100, TYSONS VA 22102